|
NUP205 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.39630000000002E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.421690E-02 |
| Normal-vs-Stage2 |
1.149650E-01 |
| Normal-vs-Stage3 |
1.076360E-01 |
| Normal-vs-Stage4 |
1.265720E-02 |
| Stage1-vs-Stage2 |
6.352400E-01 |
| Stage1-vs-Stage3 |
8.925600E-01 |
| Stage1-vs-Stage4 |
5.776200E-01 |
| Stage2-vs-Stage3 |
7.524400E-01 |
| Stage2-vs-Stage4 |
9.723600E-01 |
| Stage3-vs-Stage4 |
7.920800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.421700E-04 |
| Normal-vs-AfricanAmerican |
1.040060E-02 |
| Normal-vs-Asian |
1.653430E-01 |
| Caucasian-vs-AfricanAmerican |
9.820800E-01 |
| Caucasian-vs-Asian |
7.987000E-01 |
| AfricanAmerican-vs-Asian |
7.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.956000E-03 |
| Normal-vs-Female |
4.10849999999963E-05 |
| Male-vs-Female |
2.549700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.223700E-02 |
| Normal-vs-Extreme_Weight |
7.798200E-02 |
| Normal-vs-Obese |
3.801700E-03 |
| Normal-vs-Extreme_Obese |
6.817200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.368800E-01 |
| Normal_Weight-vs-Obese |
5.041800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.280000E-01 |
| Extreme_Weight-vs-Obese |
4.204400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.029000E-01 |
| Obese-vs-Extreme_Obese |
9.029800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.846100E-04 |
| Normal-vs-Age(41-60Yrs) |
5.73459999999582E-05 |
| Normal-vs-Age(61-80Yrs) |
4.974100E-02 |
| Normal-vs-Age(81-100Yrs) |
6.918800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.500610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.273830E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.538200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.752200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.004800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.470000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.56244999999222E-05 |
| Normal-VS-Type2 PRCC |
8.844600E-01 |
| Normal-VS-KIRP CIMP |
1.993720E-02 |
| Normal-VS-Unclassified PRCC |
7.104500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.143500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.054800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.587000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.920500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.090170E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.573560E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.016200E-01 |
| Normal-vs-N1 |
2.681600E-02 |
| Normal-vs-N2 |
2.470600E-01 |
| N0-vs-N1 |
4.141800E-02 |
| N0-vs-N2 |
9.674300E-02 |
| N1-vs-N2 |
8.841000E-01 |
|
|
